---
title: "603222.SH (603222.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603222.SH/news.md"
symbol: "603222.SH"
name: "603222.SH"
parent: "https://longbridge.com/en/quote/603222.SH.md"
datetime: "2026-06-13T16:31:40.551Z"
locales:
  - [en](https://longbridge.com/en/quote/603222.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603222.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603222.SH/news.md)
---

# 603222.SH (603222.SH) — Related News

### [Chimin: The holding subsidiary has obtained a qualified notice for the transfer of a patent right](https://longbridge.com/en/news/287507086.md)
*2026-05-25T07:39:39.000Z*
> Chimin announced that its holding subsidiary, Hainan Chimin Boao International Hospital Co., Ltd., has completed the pat

### [Chimin's controlling shareholder terminates the agreement to transfer company shares](https://longbridge.com/en/news/285686928.md)
*2026-05-08T08:12:03.000Z*
> Chimin's controlling shareholder, Shuangge Group, signed a share transfer agreement with Hubei Changhe No. 1 on March 6,

### [Chimin's subsidiary DB006 oncolytic adenovirus injection has received the drug clinical trial approval notice](https://longbridge.com/en/news/282001454.md)
*2026-04-08T08:21:40.000Z*
> Chimin's subsidiary Boao International Hospital recently received approval from the National Medical Products Administra

### [Chimin: The controlling shareholder intends to transfer 5% of the company's shares at a price of 7.72 yuan per share](https://longbridge.com/en/news/281855276.md)
*2026-04-07T09:10:57.000Z*
> Chimin Health issued a notice of unusual movement, stating that on March 6, 2026, its controlling shareholder, Shuangge 

### [](https://longbridge.com/en/news/281470825.md)
*2026-04-02T05:43:21.000Z*
> China's A-share pharmaceutical industry chain continues to strengthen, with Chimin and CMC hitting the daily limit, foll

### [Chimin: Subsidiary plans to introduce strategic investors and increase capital by 183 million yuan](https://longbridge.com/en/news/280593308.md)
*2026-03-26T08:40:41.000Z*
> Chimin announced that its wholly-owned subsidiary Ezhou Second Hospital plans to introduce a strategic investor, Changhe

### [With a related capital increase of 183 million, Chimin is "blood transfusing" its loss-making subsidiary for self-rescue](https://longbridge.com/en/news/279745604.md)
*2026-03-19T08:02:06.000Z*
> Chimin Health Management Co., Ltd. announced that its wholly-owned subsidiary Ezhou Second Hospital has introduced Hubei

### [](https://longbridge.com/en/news/279520826.md)
*2026-03-18T02:25:11.000Z*
> The A-share innovative drug sector fluctuated upward, with HUALAN NPM and Rongchang Bio reaching intraday highs, VCANBIO